The effect of hepatitis C virus infection on health-related quality of life in prisoners

Journal of Urban Health

Volumn 83, Issue 2, 2006, Pages 275-288

  Thein, Hla Hla ^a   Butler, Tony ^b,c   Krahn, Murray ^d   Rawlinson, William ^e   Levy, Michael H ^b   Kaldor, John M ^a   Dore, Gregory J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Justice Health Centre for Health Research in Criminal Justice   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

^e PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Australia; HCV; Prisoner; Quality of life; SF 36

Indexed keywords

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; AUSTRALIA; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; PRISONER; QUALITY OF LIFE; SCREENING TEST; SHORT FORM 36; VENOUS BLOOD; VIREMIA; ADDICTION; CROSS-SECTIONAL STUDY; DEPRESSION; MENTAL HEALTH; PATHOPHYSIOLOGY; PRISON; PSYCHOLOGICAL ASPECT; SELF EVALUATION; SICKNESS IMPACT PROFILE;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HEPATITIS C; HUMANS; MALE; MENTAL HEALTH; NEW SOUTH WALES; PRISONERS; PRISONS; QUALITY OF LIFE; SELF ASSESSMENT (PSYCHOLOGY); SICKNESS IMPACT PROFILE; SUBSTANCE-RELATED DISORDERS;

EID: 33746738849     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-005-9015-4     Document Type: Article

References (39)

1. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology. 1999;29:264-270.
2. Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology. 1999;30:550-555.
3. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998;27:209-212.
4. Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok AS. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol. 2002;36:401-407.
5. Fontana RJ, Moyer CA, Sonnad S, et al. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol. 2001;96:170-178.
6. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol. 2001;96:2737-2744.
7. Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology. 2004;39:74-80.
8. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology. 1999;30:1299-1301.
9. McHutchison JG, Ware JE Jr, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol. 2001;34:140-147.
10. Butler T, Allnutt S, Cain D, Owens D, Muller C. Mental disorder in the New South Wales prisoner population. Aust N Z J Psychiatry. 2005;39:407-413.
11. Butler T, Milner L. The 2001 Inmate Health Survey. 2003. Sydney: NSW Corrections Health Service. ISBN: 0 7347 3560 X.
12. Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners - NSW, 1996. Aust N Z J Public Health. 1999;23:377-384.
13. Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997;166:127-130.
14. Charlson ME, Pompei P, Ales KL, MacKenzie RC. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
15. Darke S, Ward J, Zador D, Swift G. A scale for estimating the health status of opioid users. Br J Addict. 1991;86:1317-1322.
16. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
17. Likert R. A technique for the measurement of attitudes. Arch Psych. 1932;140:5-55.
18. Ware JE, Konsinski M. SF-36®Physical &Mental Health Summary Scales: a Manual for Users of Version 1. 2nd ed. Lincoln, Rhode Island: Quality Metric Incorporated; 2001.
19. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, New York: Guildford; 1979.
20. Butler T, Kariminia A, Levy M, Kaldor J. Prisons are a risk for hepatitis C transmission. Eur J Epidemiol. 2004;19:1119-1122.
21. Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;16:167-188.
22. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman and Hall; 1991.
23. Australian Bureau of Statistics (ABS). National Health Survey: SF-36 population norms. Canberra: Australian Government Publishing Service; 1997.
24. Howell DC. Statistical Methods for Psychology. 5th ed. California: Thomson Learning; 2002.
25. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Academic; 1988.
26. Nunnally JC. Psychometric Theory. New York: McGraw-Hill; 1978.
27. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993.
28. Matthews G, Kronborg IJ, Dore GJ. Treatment for hepatitis C virus infection among current injection drug users in Australia. Clin Infect Dis. 2005;40(Suppl 5):S325-S329.
29. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology. 2005;41:790-800.
30. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35:433-439.
31. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001;358:38-39.
32. Fiala M, Looney DJ, Stins M, et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med. 1997;3:553-564.
33. Forton D, Taylor-Robinson S, Karayiamnis P, Thomas H. Identification of brain-specific quasispecies variants of hepatitis C virus (HCV) consistent with viral replication in the central nervous system. Hepatology. 2000;32(Suppl):269A.
34. Thomas HC, Torok ME, Forton DM, Taylor-Robinson SD. Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. J Hepatol. 1999;31(Suppl 1):152-159.
35. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661-674.
36. Schwarzinger M, Dewedar S, Rekacewicz C, et al. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology. 2004;40:1434-1441.
37. Cordoba J, Reyes J, Esteban JI, Hernandez JM. Labeling may be an important cause of reduced quality of life in chronic hepatitis C. Am J Gastroenterol. 2003;98:226-227.
38. Michelson H, Bolund C, Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res. 2000;9:1093-1104.
39. Mooney M, Hannon F, Barry M, Friel S, Kelleher C. Perceived quality of life and mental health status of Irish female prisoners. Ir Med J. 2002;95:241-243.